Jeong Oh, Choi Won Yong, Park Young Kyu
Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Jeollanam-do, Korea.
J Surg Oncol. 2009 Aug 1;100(2):115-20. doi: 10.1002/jso.21306.
Proper patient selection for multi-organ resection in T4 gastric carcinoma remains controversial. Our aim was to investigate which patients might benefit from multi-organ resection.
Among 1,775 consecutive patients receiving gastric cancer surgery, 71 had adjacent organ invasion. Short- and long-term surgical outcomes and associations between clinicopathological factors and overall survival were investigated.
Forty-seven patients underwent curative surgery with multi-organ resection, and 24 underwent non-curative surgery, with or without multi-organ resection. Postoperative morbidity and mortality rates were 31.7% and 3.3%, respectively. Patients receiving curative surgery via multi-organ resection survived longer than those without (MST, 31.5 months vs. 19.1 months, P = 0.046). Multi-organ resection did not affect survival when performed in non-curative surgery. N3 lymph node metastasis was an independent prognostic factor for poor outcome (HR = 3.89, 95% CI = 1.40-10.83) in curatively resected patients; patients with N3 lymph node metastasis showed similar survival to patients receiving non-curative surgery.
Multi-organ resection should be performed only when no incurable factors are present, and R0 resection is most likely. Multi-organ organ resection does not, however, seem to be effective in patients with N3 lymph node metastasis, even when curative resection is performed.
T4期胃癌多器官切除的合适患者选择仍存在争议。我们的目的是研究哪些患者可能从多器官切除中获益。
在1775例连续接受胃癌手术的患者中,71例存在邻近器官侵犯。对短期和长期手术结果以及临床病理因素与总生存之间的关联进行了研究。
47例患者接受了多器官切除的根治性手术,24例接受了非根治性手术,包括或不包括多器官切除。术后发病率和死亡率分别为31.7%和3.3%。通过多器官切除接受根治性手术的患者比未接受多器官切除的患者生存时间更长(中位生存时间,31.5个月对19.1个月,P = 0.046)。在非根治性手术中进行多器官切除不影响生存。N3淋巴结转移是根治性切除患者预后不良的独立预后因素(风险比 = 3.89,95%置信区间 = 1.40 - 10.83);N3淋巴结转移患者的生存情况与接受非根治性手术的患者相似。
仅当不存在不可治愈因素且最有可能实现R0切除时才应进行多器官切除。然而,即使进行根治性切除,多器官切除对N3淋巴结转移患者似乎也无效。